Additionally, a previous study that explored other pathways leading liver fibrosis found that pantoprazole was significantly fibrogenic, both in vitro and in vivo, by inhibiting the deubiquitinating enzyme OTUB2 and the Yes-associated protein signaling pathway [21]. This evidence concerns the gene OTUB2 and Hepatic fibrosis.